title: Another step on the path to better TB therapies.
authors.forename: Andrew
authors.initials: A
authors.lastname: Vernon
authors.forename: William
authors.initials: W
authors.lastname: Burman
authors.forename: C Robert
authors.initials: CR
authors.lastname: Horsburgh
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D006723:Hong Kong; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012293:Rifampin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin; C018421:rifapentine